EUVIMEDEUVIMED entdecken
Crossref

A Retrospective Study to Evaluate the Clinical Utility of Sufentanil in Critically ill and Mechanically Ventilated Children from a Singlecenter Experience

Pallavi gupta, Aman Rathore

Journal of Nepal Paediatric Society · 16.06.2026 · 46 (2) · 26-31

DOI: 10.60086/jnps.v46i2.1429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nepal Paediatric Society, online erschienen am 16.06.2026. Verfasst von Pallavi gupta und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sufentanil, an opioid analgesic, is an analogue of fentanyl, and has been used for the induction and maintenance of anaesthesia, and for postsurgical analgesia. It has shorter distribution and elimination half-lives, and is a more potent analgesic than fentanyl. Methods :This is a retrospective observational cohort study included patients under 19 years of age admitted to the pediatric intensive care unit (PICU) in a tertiary care children’s hospital between March 2024 and September 2025, in whom sufentanil was used as the first-choice continuous analgosedative drug. Results :In total, 120 patients were included. The most common reason for PICU admission was postoperative care (28.33%), followed by respiratory failure (25.0%), and cardiac problems (20%). The initial median starting and maximum doses of sufentanil were 0.5 μg/kg/hr (interquartile range [IQR], 0.3–1.0). The median durations of sufentanil use, mechanical ventilation support, and PICU stay were 1 days (IQR, 4–12), 6 days (IQR, 1–17) and 9 days (IQR, 5–27), respectively. In 97 (80.83%) patients, an appropriate analgesia/sedation level was achieved with sufentanil alone. However, 22 patients required additional drugs such as midazolam and ketamine infusion after administering the maximum dose of sufentanil, indicating the necessity for supplementary agents. No significant adverse effects or withdrawal symptoms were associated with sufentanil use.

Conclusion

Sufentanil may be a promising option for analgesia / sedation in critically ill paediatric patients, as it demonstrated no significant side effects or withdrawal symptoms.

Zitieren

APA

gupta, P., & Rathore, A. (2026). A Retrospective Study to Evaluate the Clinical Utility of Sufentanil in Critically ill and Mechanically Ventilated Children from a Singlecenter Experience. Journal of Nepal Paediatric Society, 46(2), 26-31. https://doi.org/10.60086/jnps.v46i2.1429

Vancouver

gupta P, Rathore A. A Retrospective Study to Evaluate the Clinical Utility of Sufentanil in Critically ill and Mechanically Ventilated Children from a Singlecenter Experience. Journal of Nepal Paediatric Society. 2026;46(2):26-31. doi:10.60086/jnps.v46i2.1429

BibTeX
@article{gupta2026,
  author = {gupta, Pallavi and Rathore, Aman},
  title = {A Retrospective Study to Evaluate the Clinical Utility of Sufentanil in Critically ill and Mechanically Ventilated Children from a Singlecenter Experience},
  journal = {Journal of Nepal Paediatric Society},
  year = {2026},
  volume = {46},
  number = {2},
  pages = {26--31},
  doi = {10.60086/jnps.v46i2.1429}
}
Kostenlos starten →